Skip to main content

Table 1 Patient characteristics of the 240 patients with MIBC treated with radical cystectomy 2001–2014

From: A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy

Parameter

All patients (n = 240)

Non-anemic (n = 112)

Anemic (n = 128)

p value

Age (years)

69 (62–75)

68 (61–73)

71 (65–76)

0.004

Sex

   

0.145

 Male

176 (73.3)

77 (68.8)

99 (77.3)

 

 Female

64 (26.7)

35 (31.2)

29 (22.7)

 

BMI

25.5 (22.8–28.4)

25.8 (23.8–28.8)

24.9 (22.5–27.8)

0.054

 Missing data

20

10

10

 

ASA score

   

0.024

 I

28 (11.8)

19 (17.3)

9 (7.1)

 

 II

120 (50.6)

57 (51.8)

63 (49.6)

 

 III

86 (36.3)

32 (29.1)

54 (42.5)

 

 IV

3 (1.3)

2 (1.8)

1 (0.8)

 

 Missing data

3

2

1

 

Prior heart attack

33 (13.8)

15 (13.4)

18 (14.1)

1

Hypertonia

104 (43.3)

51 (45.5)

53 (41.4)

0.602

Atrial fibrillation

19 (7.9)

8 (7.1)

11 (8.6)

0.812

Asthma/COPD

17 (7.1)

11 (9.8)

6 (4.7)

0.137

Diabetes mellitus

29 (12.1)

13 (11.6)

16 (12.5)

0.845

Hydronephrosis

63 (26.3)

19 (17)

44 (34.4)

0.003

Neoadjuvant chemotherapy

87 (36.3)

17 (15.2)

70 (54.7)

<0.001

EBL (mL)

1000 (700–1712.5)

1200 (725–2000)

1000 (650–1475)

0.035

 Missing data

26

15

11

 

Units of PBT

4 (2–6)

2 (1–6)

4 (2–6)

0.003

cT

   

0.017

 cT2

178 (72.2)

92 (82.1)

86 (67.2)

 

 cT3

51 (21.3)

18 (16.1)

33 (25.8)

 

 cT4

11 (4.6)

2 (1.8)

9 (7.0)

 

Year of surgery

   

0.469

 2001–2002

20 (8.3)

12 (10.7)

8 (6.3)

 

 2003–2005

43 (17.9)

21 (18.8)

22 (17.2)

 

 2006–2008

55 (22.9)

27 (24.1)

28 (21.9)

 

 2009–2011

73 (30.4)

34 (30.4)

39 (30.5)

 

 2012–2014

49 (20.4)

18 (16.1)

31 (24.2)

 
  1. Data are shown as median (IQR) or n (%)
  2. BMI body mass index, ASA American Society of Anesthesiologists, COPD  chronic obstructive pulmonary disease, EBL estimated blood loss, PBT perioperative blood transfusion, cT clinical tumour stage